Premium
ENDRA Life Sciences Inc (NDRA)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAE... ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. Show more
ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the minimum bid price requirement set...
Company accelerated enrollment in global multisite pilot study and significantly reduced operating expenses while refocusing resources to clinical and regulatory deliverables ENDRA Life Sciences...
ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a poster titled “Noninvasive assessment of steatotic liver...
Global Intellectual Property Portfolio Now Includes 82 Issued Patents ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.2 | 27.7777777778 | 4.32 | 6.3 | 4.32 | 64912 | 5.4935105 | CS |
| 4 | -0.48 | -8 | 6 | 6.9 | 4.2 | 62644 | 5.30248915 | CS |
| 12 | -1.823 | -24.8263652458 | 7.343 | 22.68 | 4.01 | 7745512 | 13.76021591 | CS |
| 26 | -168.255 | -96.8234786362 | 173.775 | 197.75 | 4.01 | 8055848 | 54.43730978 | CS |
| 52 | -4456.98 | -99.876302521 | 4462.5 | 4663.75 | 4.01 | 8504198 | 152.90415764 | CS |
| 156 | -27994.48 | -99.9802857143 | 28000 | 28763 | 4.01 | 3187803 | 1233.17137756 | CS |
| 260 | -46544.48 | -99.988141783 | 46550 | 108500 | 4.01 | 2187289 | 9695.62386847 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
